Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Colorcon
Harvard Business School
Dow
Moodys

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Triheptanoin

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Triheptanoin?

Triheptanoin is an investigational drug.

There have been 32 clinical trials for Triheptanoin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Syndrome, Carbohydrate Metabolism, Inborn Errors, and Glycogen Storage Disease. The leading clinical trial sponsors are Ultragenyx Pharmaceutical Inc, University of Texas Southwestern Medical Center, and Institut National de la Santé Et de la Recherche Médicale, France.

Recent Clinical Trials for Triheptanoin
TitleSponsorPhase
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type IUltragenyx Pharmaceutical IncEarly Phase 1
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type IAreeg El-GharbawyEarly Phase 1
A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)Ultragenyx Pharmaceutical IncPhase 1/Phase 2

See all Triheptanoin clinical trials

Clinical Trial Summary for Triheptanoin

Top disease conditions for Triheptanoin
Top clinical trial sponsors for Triheptanoin

See all Triheptanoin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Moodys
Johnson and Johnson
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.